SCHEMBL4814889

SCHEMBL4814889

CC1(C)CCN(C(=O)Cc2ccc(-c3ccccc3)cc2)C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.59
NPY5R Q15761 1/20 0.57
HRH3 Q9Y5N1 2/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
TSHR P16473 3/20 0.56
NAAA Q02083 2/20 0.50
FAAH O00519 1/20 0.50
CRBN Q96SW2 1/20 0.50
HSD11B1 P28845 3/20 0.48
LMNA P02545 2/20 0.47
ABCC4 O15439 1/20 0.47
GAA P10253 1/20 0.47
PTGS1 P23219 1/20 0.47
HTT P42858 1/20 0.47
ALDH1A1 P00352 2/20 0.46
USP2 O75604 1/20 0.46
CYP3A4 P08684 1/20 0.46
HPGD P15428 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4819767 0.91 CRBN (0.58) SMN1; SMN2TSHRCRBNHSD11B1LMNA
SCHEMBL4819750 0.91 CRBN (0.58) SMN1; SMN2TSHRCRBNHSD11B1LMNA
SCHEMBL14297333 0.84 MEN1 (0.56) SMN1; SMN2HSD11B1LMNAGAAALDH1A1
SCHEMBL4817875 0.82 HSD11B1 (0.68) MAPTSMN1; SMN2HSD11B1ALDH1A1USP2
SCHEMBL4817865 0.82 HSD11B1 (0.68) MAPTSMN1; SMN2HSD11B1ALDH1A1USP2
SCHEMBL4820067 0.80 HSD11B1 (0.48) HRH3SMN1; SMN2CRBNHSD11B1
SCHEMBL4820081 0.80 HSD11B1 (0.48) HRH3SMN1; SMN2CRBNHSD11B1
SCHEMBL4813560 0.78 MAPK1 (0.61) SMN1; SMN2TSHRLMNAALDH1A1USP2
SCHEMBL4814895 0.77 NAAA (0.50) MAPTNPY5RHRH3SMN1; SMN2TSHR
SCHEMBL4817713 0.77 FAAH (0.56) SMN1; SMN2FAAHLMNAGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7402606-B2 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss SMITHKLINE BEECHAM CORPORATION (US) 2008-07-22 US claimed
EP-1494663-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SmithKline Beecham Corporation (US) 2005-01-12 EP claimed
WO-2003086385-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-23 WO claimed
US-7402606-B2 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss SMITHKLINE BEECHAM CORPORATION (US) 2008-07-22 US disclosed